S

Soleno Therapeutics
D

SLNO

68.120
USD
-1.63
(-2.34%)
مفتوح الان
حجم التداول
23,329
الربح لكل سهم
-3
العائد الربحي
-
P/E
-16
حجم السوق
3,143,058,725
أصول ذات صلة
ABBV
ABBV
-2.390
(-1.28%)
183.550 USD
ALNY
ALNY
-7.315
(-3.04%)
233.495 USD
C
CRMD
1.02000
(16.80%)
7.09000 USD
G
GLPG
0.470
(1.98%)
24.190 USD
GSK
GSK
-0.275
(-0.79%)
34.560 USD
MRK
MRK
-0.220
(-0.27%)
80.590 USD
PFE
PFE
-0.810
(-3.51%)
22.215 USD
T
TTNP
-0.29000
(-7.40%)
3.63000 USD
المزيد
الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.